Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mulu Z Tesfay

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Virology|September 5, 2008
Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesisChristina L Gardner, Crystal W Burke, Mulu Z Tesfay, et al.
Frontiers in Immunology|February 16, 2024
Pancreatic cancer tumor microenvironment is a major therapeutic barrier and targetConner Hartupee, Bolni Marius Nagalo, Chiswili Y Chabu, et al.
Journal of Virology|March 21, 2014
Vesiculovirus neutralization by natural IgM and complementMulu Z Tesfay, Arun Ammayappan, Mark J Federspiel, et al.
Journal of Virology|December 28, 2007
Alpha/beta interferon inhibits cap-dependent translation of viral but not cellular mRNA by a PKR-independent mechanismMulu Z Tesfay, Jun Yin, Christina L Gardner, et al.
Journal of Virology|January 18, 2013
PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized miceMulu Z Tesfay, Amber C Kirk, Elizabeth M Hadac, et al.
Molecular Therapy. Oncology|March 24, 2025
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinomaChelsae R Watters, Oumar Barro, Musa Gabere, et al.
Molecular Therapy Oncolytics|July 13, 2018
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV<sup>POS</sup> CancersLukkana Suksanpaisan, Rong Xu, Mulu Z Tesfay, et al.
Frontiers in Immunology|September 10, 2025
Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defensesTolulope O Omolekan, Joy T Folahan, Mulu Z Tesfay, et al.
Biomedicines|July 27, 2024
Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic CancerKhandoker Usran Ferdous, Mulu Z Tesfay, Aleksandra Cios, et al.
Frontiers in Oncology|December 2, 2022
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapyYuguo Zhang, Musa Gabere, Mika A Taylor, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Virology|September 5, 2008
Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesisChristina L Gardner, Crystal W Burke, Mulu Z Tesfay, et al.
Frontiers in Immunology|February 16, 2024
Pancreatic cancer tumor microenvironment is a major therapeutic barrier and targetConner Hartupee, Bolni Marius Nagalo, Chiswili Y Chabu, et al.
Journal of Virology|March 21, 2014
Vesiculovirus neutralization by natural IgM and complementMulu Z Tesfay, Arun Ammayappan, Mark J Federspiel, et al.
Journal of Virology|December 28, 2007
Alpha/beta interferon inhibits cap-dependent translation of viral but not cellular mRNA by a PKR-independent mechanismMulu Z Tesfay, Jun Yin, Christina L Gardner, et al.
Journal of Virology|January 18, 2013
PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized miceMulu Z Tesfay, Amber C Kirk, Elizabeth M Hadac, et al.
Molecular Therapy. Oncology|March 24, 2025
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinomaChelsae R Watters, Oumar Barro, Musa Gabere, et al.
Molecular Therapy Oncolytics|July 13, 2018
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV<sup>POS</sup> CancersLukkana Suksanpaisan, Rong Xu, Mulu Z Tesfay, et al.
Frontiers in Immunology|September 10, 2025
Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defensesTolulope O Omolekan, Joy T Folahan, Mulu Z Tesfay, et al.
Biomedicines|July 27, 2024
Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic CancerKhandoker Usran Ferdous, Mulu Z Tesfay, Aleksandra Cios, et al.
Frontiers in Oncology|December 2, 2022
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapyYuguo Zhang, Musa Gabere, Mika A Taylor, et al.
Pageof 2